about
MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner.YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinomaRequirement for MUC5AC in KRAS-dependent lung carcinogenesis
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Current Landscape of Targeted Therapy in Lung Cancer.
@en
Current Landscape of Targeted Therapy in Lung Cancer.
@nl
type
label
Current Landscape of Targeted Therapy in Lung Cancer.
@en
Current Landscape of Targeted Therapy in Lung Cancer.
@nl
prefLabel
Current Landscape of Targeted Therapy in Lung Cancer.
@en
Current Landscape of Targeted Therapy in Lung Cancer.
@nl
P2860
P356
P1476
Current Landscape of Targeted Therapy in Lung Cancer.
@en
P2093
Manasi K Mayekar
Trever G Bivona
P2860
P304
P356
10.1002/CPT.810
P407
P577
2017-08-08T00:00:00Z